Proactive Investors - Run By Investors For Investors

ShareRoot advancing audit of company strategy and proprietary technologies

The company operates in the social media marketing and privacy protection ecosystem
technology ecosystem
Last month, ShareRoot entered a collaboration with Cancer Trials Australia

ShareRoot Ltd (ASX:SRO) is progressing an audit of company strategy and proprietary technologies which is expected to be completed by the end of the month.

ShareRoot chairman Harvey Kaplan said: “Considering the recent change in operational and strategic leadership it is appropriate that the board undertakes a thorough review of the company’s progress to date and the current and prospective value of the assets.”

READ: ShareRoot collaborates to support cancer research with MediaConsent

Last month, the company entered a collaboration that will see its MediaConsent platform used in a cancer clinical trial setting.

The collaboration is with Cancer Trials Australia (CTA) and the medical project is being led by The Social Science (TSS).

The MediaConsent Medical project now has three health or medical research related collaborators being St Vincent’s Hospital, Melbourne, Neuroscience Trials Australia, and CTA.

The shared goal with the MediaConsent clinical collaboration is to demonstrate how ShareRoot’s technology protects patient data and privacy whilst supporting the advancement of clinical research.

View full SRO profile View Profile

ShareRoot Ltd Timeline

Related Articles

Hundred dollar bills float through air, signalling affluence of Animoca's partnerships
April 23 2019
Animoca Brands is a rapidly growing games company always on the move and seeking new growth opportunities.
Bitcoin coins in a wallet
December 22 2018
The payment processing company’s platform has continued to sign up merchants, unbothered by the notorious market volatility
Mergers and acquisitions graphic
January 17 2019
Swift’s investors will vote on its planned acquisition of ad specialist Medical Media.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use